Dassault Systèmes Earnings Call: Profitability Amid Headwinds

Dassault Systemes S.A. (ADR) ((DASTY)) has held its Q4 earnings call. Read on for the main highlights of the call.

Dassault Systèmes’ latest earnings call struck a cautiously optimistic tone. Management emphasized solid profitability, strong cash generation, cloud and ARR momentum, and a promising strategic position in industrial AI, even as 2025 growth fell short of earlier ambitions due to MEDIDATA, Centric and European auto headwinds.

Full-Year 2025 Revenue and Profitability

Dassault Systèmes delivered full-year 2025 revenue of EUR 6,240 million, with software revenue growing 4% on a constant-currency basis despite the macro and sector pressures. Operating profit reached EUR 1,994 million, driving a 32% margin that expanded 40 basis points year on year and supported a 7% rise in EPS to EUR 1.31.

Q4 Results and Margin Expansion

Fourth-quarter revenue came in at EUR 1,682 million, up 1% ex-FX, as software revenue was essentially flat at plus 0.3% amid product and geographic softness. However, profitability continued to improve, with Q4 operating profit at EUR 622 million and margin climbing to 37%, up 90 basis points ex-FX, lifting quarterly EPS 9% ex-FX to EUR 0.40.

Recurring Revenue and Subscription Momentum

The company’s recurring model remains a key strength, with recurring revenue up 6% in 2025 and now accounting for 82% of software revenue, providing improved visibility and resilience. Subscription revenue rose 11% for the year and 4% in Q4, while services grew 11% in the quarter, and management expects subscription to overtake maintenance in 2026.

ARR Introduction and Growth Trajectory

Dassault introduced annual recurring revenue as a central metric ahead of a fuller transition in 2026 reporting, underscoring the shift to a more subscription-driven business. ARR reached nearly EUR 4.5 billion in Q4, with around EUR 100 million net additions in the quarter and approximately 6% average growth over the past two years, highlighting underlying demand despite modest reported revenue growth.

3DEXPERIENCE and Cloud Momentum

The 3DEXPERIENCE platform continued to gain scale, with revenue up 10% in 2025 and now representing roughly 40% of software sales, reinforcing its role as a core growth engine. Cloud performance was particularly strong for 3DEXPERIENCE, with Q4 growth of about 38% and 32% for the year, while overall group cloud revenue rose 9% in Q4 and 8% in 2025.

Cash Flow Strength and Balance Sheet Resilience

Operating cash flow rose to EUR 1,630 million, up 1% ex-FX, supporting free cash flow growth of roughly 2% ex-FX despite currency and tax headwinds. Cash conversion remained robust at 82%, above prior expectations, with cash and cash equivalents at EUR 4,125 million and net cash of EUR 1,530 million providing ample flexibility for investment and shareholder returns.

Strategic AI Positioning and Partnerships

Management showcased new AI-native offerings, including 3D UNIV+RSES, Virtual Companions, Generative Experiences and Virtual Twin-as-a-Service, positioning Dassault at the intersection of industrial AI and virtual twins. A highlighted partnership with NVIDIA and an early backlog of about EUR 50 million for these AI products within roughly six months signal credible initial commercial traction in this emerging area.

Product, Industry Wins and Market Position

The company reported competitive displacements and strategic multi-year 3DEXPERIENCE deals across high-tech, transportation and mobility, and aerospace and defense, underscoring a strong position in core verticals. Asia remained a relative bright spot, with Q4 growth of 6% and 5% for the year, partially offsetting softness elsewhere and supporting the long-term growth narrative.

Operational Productivity and Margin Leverage

Productivity improvements were a notable contributor to margin expansion, particularly in Q4 where operating margin rose 90 basis points ex-FX, reflecting disciplined cost control and efficiency gains. Management signaled confidence in continued operational leverage, guiding for a further 40 to 80 basis points ex-FX margin improvement in 2026, even on conservative top-line assumptions.

Centric and MEDIDATA Actions and Enterprise Wins

Management outlined corrective actions at Centric, including new leadership and completion of the ContentServ integration, with expectations for a marked recovery and a return to low-teens growth in 2026. At MEDIDATA, enterprise momentum was better than headlines suggest, with wins or win-backs at large pharma clients such as Novartis, Merck, AbbVie and Gilead leading to about 6% growth in enterprise excluding Moderna.

Below-Target Growth in 2025

Despite healthy margins and cash, management openly acknowledged that 2025 growth was disappointing versus its long-term plan and finished at the low end of internal objectives. Total revenue growth of around 4% ex-FX missed previous ambitions, reinforcing the need for execution on product transitions, recovery in challenged segments and conversion of ARR into reported revenue.

Life Sciences Headwinds and Client Impact

Life Sciences software revenue fell 4% in Q4 and 2% for the full year, with MEDIDATA a significant drag as the sector faced fewer trial starts and budget rationalization. A more than 50% reduction in contract run rate from a major client, Moderna, materially hit growth and has led management to stay cautious on near-term recovery prospects in this important vertical.

Centric Decline and Transition Challenges

Centric’s performance was another major headwind, with double-digit declines in Q4 driven by renewal timing shifts and the ongoing move to cloud. While management anticipates a turnaround as the new structure beds in, the depth of Q4 weakness underscores the execution risk inherent in portfolio transitions and the importance of stabilizing this business in 2026.

European Auto Market Weakness

Regional dynamics added to the pressure, with Europe down 5% in Q4 despite growing 2% for the year, as France and Germany suffered from a weak automotive sector. Dassault has proactively trimmed its pipeline exposure and lowered near-term expectations for auto demand, suggesting that investors should not count on a quick rebound from this end-market.

Revenue Recognition Mismatch Versus ARR

One theme across the call was the disconnect between solid ARR additions and muted reported revenue, with Q4 software revenue up just 0.3% despite EUR 100 million in net ARR additions. Management pointed to timing and accounting differences between ARR and revenue as a source of volatility, which may obscure underlying demand trends for a few quarters.

FX and One-Off Cash Headwinds

Foreign-exchange movements and one-off items weighed on cash metrics, with currency alone cutting roughly EUR 263 million from cash year on year and new employer contributions plus an exceptional French tax reducing operating cash flow by about EUR 40 million. Cash conversion eased from 84% to 82%, but remained strong and within a range consistent with a resilient financial profile.

Uncertain New Monetization Models

The shift to value- and usage-based pricing for AI offerings, including Virtual Companions and outcome-based contracts, is still in its early stages and introduces new forecasting challenges. Management shared high-level unit economics but acknowledged that revenue visibility and predictability for consumption and outcome models is limited for now, adding another layer of execution risk.

Geographic and Product Soft Spots

Beyond Europe’s auto exposure, China had a softer quarter against tough comparisons, tempering overall regional momentum in Asia. In Life Sciences, the CRO and volume-driven business, particularly the indirect side tied to study starts, declined about 5% year on year, further complicating the near-term growth picture for that segment.

RPO Ambiguity and Visibility Concerns

Investors looking for additional clarity on remaining performance obligations were left with some unanswered questions, as management did not provide a detailed bridge between RPO dynamics and revenue guidance. With RPO timing potentially volatile, this lack of granularity may reduce short-term visibility on how contract backlog converts to reported revenue.

Conservative 2026 Guidance and Outlook

For 2026, management set what it called derisked targets, guiding for 3–5% ex-FX growth in both total and software revenue and an operating margin of 32.2–32.6%, up 40–80 basis points ex-FX. EPS is expected to rise 3–6% ex-FX to EUR 1.30–1.34, with Q1 revenue guided to 1–5% growth and margin of 29.2–30.7%, as the company leans into subscription, begins formal ARR reporting and deliberately excludes any benefit from mega deals or a rapid MEDIDATA rebound.

Dassault Systèmes’ earnings call painted a picture of a company with healthy profitability, strong cash and strategic assets in cloud and AI, but facing real near-term growth challenges in Life Sciences, Centric and European autos. For investors, the story now hinges on whether conservative guidance, ARR growth and AI-driven opportunities can translate into a steadier and faster growth trajectory beyond 2026.